When my doc saw the writing on the wall and Anatabloc heading off the shelf, he stocked up. Obviously the product is expired now, but I don't think he is worried about that. It's too bad that people like his two Alzheimer's patients (mild to moderate) who were being helped could not stock up, along with many others who were helped by anatabine citrate. But from what I hear from our group here, there are now at least five more pharma companies that have received info about anatabine that seem to have never heard of it before.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.